HRTS vs. XPH ETF Comparison
Comparison of Tema Cardiovascular and Metabolic ETF (HRTS) to SPDR S&P Pharmaceuticals ETF (XPH)
HRTS
Tema Cardiovascular and Metabolic ETF
HRTS Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$30.77
Average Daily Volume
14,144
36
XPH
SPDR S&P Pharmaceuticals ETF
XPH Description
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.Grade (RS Rating)
Last Trade
$46.34
Average Daily Volume
60,002
44
Performance
Period | HRTS | XPH |
---|---|---|
30 Days | -9.25% | -0.77% |
60 Days | -11.27% | 3.73% |
90 Days | -12.29% | 5.39% |
12 Months | 15.50% | 28.11% |
HRTS Overweight 34 Positions Relative to XPH
Symbol | Grade | Weight | |
---|---|---|---|
VRTX | D | 5.64% | |
AMGN | F | 5.11% | |
ALNY | D | 4.95% | |
CRNX | C | 4.0% | |
BBIO | F | 3.69% | |
CYTK | F | 3.47% | |
BSX | A | 2.99% | |
ASND | F | 2.88% | |
MDT | D | 2.79% | |
MIRM | B | 2.6% | |
DXCM | C | 2.57% | |
MREO | F | 2.49% | |
IONS | F | 2.42% | |
MASI | B | 2.39% | |
REGN | F | 2.37% | |
KROS | D | 2.1% | |
EW | C | 1.91% | |
MLYS | F | 1.89% | |
PODD | C | 1.88% | |
RCKT | F | 1.8% | |
ARWR | D | 1.76% | |
RARE | F | 1.71% | |
NTLA | F | 1.66% | |
MDGL | B | 1.46% | |
WST | C | 1.43% | |
AKRO | B | 1.28% | |
NVS | F | 1.26% | |
VKTX | F | 1.14% | |
NARI | C | 0.97% | |
SLN | F | 0.91% | |
TERN | F | 0.7% | |
VERV | F | 0.64% | |
TNYA | D | 0.43% | |
RANI | F | 0.31% |
HRTS Underweight 42 Positions Relative to XPH
Symbol | Grade | Weight | |
---|---|---|---|
CORT | B | -4.96% | |
LBPH | A | -4.12% | |
BMY | B | -4.11% | |
ITCI | C | -4.01% | |
JAZZ | B | -3.94% | |
VTRS | A | -3.73% | |
AXSM | B | -3.59% | |
CTLT | C | -3.41% | |
ELAN | D | -3.35% | |
PRGO | C | -3.35% | |
RPRX | D | -3.18% | |
JNJ | C | -3.17% | |
ZTS | D | -3.15% | |
PFE | F | -3.07% | |
MRK | D | -2.93% | |
TARS | C | -2.81% | |
OGN | F | -2.58% | |
SAVA | C | -2.57% | |
ARVN | F | -2.53% | |
PBH | A | -2.5% | |
SUPN | C | -2.15% | |
AMPH | F | -2.02% | |
PCRX | C | -1.91% | |
LGND | C | -1.77% | |
ANIP | F | -1.54% | |
COLL | F | -1.48% | |
OCUL | D | -1.44% | |
AMRX | C | -1.33% | |
MNMD | C | -1.23% | |
HRMY | D | -1.22% | |
WVE | C | -1.17% | |
HROW | D | -1.17% | |
INVA | D | -0.98% | |
EYPT | D | -0.94% | |
LQDA | F | -0.89% | |
PLRX | D | -0.87% | |
FULC | F | -0.85% | |
ELVN | D | -0.64% | |
NUVB | C | -0.6% | |
EOLS | D | -0.52% | |
PHAT | F | -0.48% | |
XERS | C | -0.46% |
HRTS: Top Represented Industries & Keywords
XPH: Top Represented Industries & Keywords